Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 2232-2235, 2002;
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beutler, E.
Right arrow Articles by Lee, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beutler, E.
Right arrow Articles by Lee, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Hematology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:2232-2235.)
© 2002 American Association for Clinical Chemistry, Inc.

Haptoglobin Polymorphism and Iron Homeostasis

Ernest Beutler1a, Terri Gelbart1 and Pauline Lee1

1 The Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Rd., La Jolla, CA 92037.

aAuthor for correspondence. Fax 858-784-2083.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: There is a marked difference in the degree of expression of the homozygous C282Y HFE genotype that is associated with hereditary hemochromatosis. It has been reported that individuals with the haptoglobin 2-2 type manifest increased iron concentrations, including serum iron, transferrin saturation, and ferritin.

Methods: We studied 232 patients, 115 homozygous for the c.845G->A (C282Y) mutation and 117 matched controls with the wild-type HFE genotype, for haptoglobin phenotypes. Haptoglobin types were determined by electrophoresis of the denatured protein. The HFE genotype was determined by allele-specific oligonucleotide hybridization. Ferritin and transferrin saturation were measured by standard methods.

Results:There was no relationship between haptoglobin type and ferritin concentration or transferrin saturation.

Conclusions: The effect of haptoglobin type on iron homeostasis cannot account for the marked phenotypic variation that is seen in patients homozygous for the HFE C282Y mutation.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The c.845G->A (C282Y) mutation of the HFE gene is common, but of the many homozygotes in the Northern European population, ~5 per 1000, only very few develop clinical hemochromatosis. Indeed, only approximately one-half manifest increased ferritin concentrations, even when past middle age (1)(2). Clearly, other factor(s) determine whether clinical hemochromatosis will develop in homozygotes.

Recently, groups in France and Belgium have reported that a common haptoglobin polymorphism is a risk factor in men homozygous for the C282Y HFE mutation and in men from the general population (3)(4)(5). It was suggested that serum iron, transferrin saturation, and serum and monocyte ferritin concentrations were increased in men with the 2-2 haptoglobin phenotype. We have typed 232 patients, 115 homozygous for the c.845G->A (C282Y) mutation and 117 matched controls who have the wild-type/wild-type (wt/wt) genotype. We have been unable to find any relationship between the haptoglobin type and iron concentrations.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
patients
The patient population and methods for the determination of serum ferritin and transferrin saturation have been described previously (1)(2)(6). Briefly, these patients attended the Health Appraisal Clinic at Kaiser-Permanente in Southern California. HFE genotyping was performed on >41 000 individuals who volunteered to participate in a study of hemochromatosis. Only those homozygous for the C282Y mutation for whom serum ferritin and transferrin saturation values were available before having undergone phlebotomy were included. Table 1 summarizes the demographic characteristics of the patient sample. The controls were homozygous wild-type individuals, matched to the C282Y/C282Y homozygotes by sex, age, and ethnic origin for the determination of serum collagen IV in a previous study (2). For a few participants, plasma was not available for genotyping.


View this table:
[in this window]
[in a new window]
 
Table 1. Demographic characteristics of the population studied.

haptoglobin typing
Type 2 haptoglobin is the product of a gene with a major internal duplication; the haptoglobin type can therefore be determined on the basis of the molecular mass by electrophoresis of the {alpha}-chain of the denatured protein. A modification of the method of Craig et al. (7) was used. We diluted 1 µL of human EDTA plasma that had been stored for up to 2 years at -70 °C in 20 µL of sample loading buffer [10 g/L sodium dodecyl sulfate, 100 mL/L glycerol, 25 mmol/L Tris (pH 6.8), 0.05 g/L bromphenol blue, and 50 mL/L ß-mercaptoethanol] and boiled the mixture for 5 min. We then loaded 5 µL of the boiled sample on a precast 15% polyacrylamide gel (9 x 10 cm) from BioWhittaker. Standard haptoglobin samples of types 1-1 and 2-2 (Sigma Chemical Co.) were diluted to 1 g/L and treated in the same fashion. Samples were electrophoresed in 25 mmol/L Tris base–192 mmol/L glycine–1 g/L sodium dodecyl sulfate for 45 min at 150 V and then transferred to Protran® (Schleicher and Schuell) nitrocellulose membranes. The membranes were blocked in 20 g/L bovine serum albumin in Tris-buffered Tween [TBST; 10 mmol/L Tris-HCl (pH 8.0), 150 mmol/L NaCl, 0.5 mL/L Tween 20] for 1 h and then incubated at 4 °C overnight with a 1:1000 dilution of polyclonal rabbit anti-human haptoglobin (Sigma) as a primary antibody. After washing the membrane three times in TBST, we added a second antibody, anti-rabbit IgG Fc alkaline phosphate conjugate (Promega) diluted 1:7500 in TBST; the membrane was then incubated at room temperature for 1 h. The membrane was washed three times in TBST and finally developed with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate color development substrate (Promega).


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
As shown in Fig. 1 , {alpha}- and ß-haptoglobin bands were visible after incubation with polyclonal rabbit anti-human haptoglobin. The {alpha} bands determine the 1-1, 1-2, and 2-2 haptoglobin types.



View larger version (76K):
[in this window]
[in a new window]
 
Figure 1. Detection of haptoglobin haplotypes by Western blotting.

The arrows indicate the sizes of the type 1 and 2 {alpha}-chains. The larger fragments that are stained with antibodies are presumably the ß-chains.

The validity of the immunoblotting method for determining haptoglobin genotypes was confirmed by examining genomic DNA from the same individual by multiplex PCR. Two different sense primers, one common to haptoglobin types 1 and 2, the other specific only to haptoglobin type 2, were used with a common antisense primer:

The DNA from those individuals who were haptoglobin type 1 yielded only a 225-bp PCR fragment. The DNA from individuals who were haptoglobin type 2 yielded two bands, 225 and 332 bp in length, that were of equal intensity. The DNA from individuals heterozygous for type 1 and 2 also yielded two bands of 225 and 332 bp, but the intensity of the 225-bp band was greater because it is represented in both haptoglobin type 1 and type 2, whereas the 332-bp band is amplified only from haptoglobin type 2. The Western blot-based method was chosen as the least error-prone because evaluation of intensity of bands was not required for interpretation. However, in every case in which both methods were used, the same result was obtained.

The distribution of haptoglobin types in the population studied is shown in Table 2 . There was no significant difference in the gene frequencies in the various subgroups studied, nor was there significant deviation from the expected Hardy–Weinberg distribution for the genotypes.


View this table:
[in this window]
[in a new window]
 
Table 2. Distribution of haptoglobin types in the study population.

The relationship between serum ferritin and transferrin saturation in the different haptoglobin types among the men is shown in Fig. 2 . The values in women were somewhat lower, but there was again no significant difference between different haptoglobin types (data not shown).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. Relationship between haptoglobin type and serum ferritin (top) and transferrin saturation (bottom) in males.

{square}, homozygotes for the C282Y mutation of HFE; {triangleup}, patients with the wild-type genotype. The horizontal lines denote the geometric means of the ferritin values and the arithmetic mean of transferrin saturation.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
It is not known whether the factors that determine which homozygotes for the C282Y mutation develop clinical disease are primarily genetic or environmental. On the basis of the presumption that genetic polymorphisms may be important modifiers of the expression of HFE mutations, we have examined polymorphisms encoding 15 genes (8)(9) involved in iron homeostasis, utilizing a large database obtained in Southern California. Although we found that one of the polymorphisms of the transferrin gene is a risk factor for iron deficiency anemia in women (10), no other polymorphism was found that significantly increased the transferrin saturation or serum ferritin concentrations of either homozygotes for the C282Y mutation or patients with a wt/wt HFE genotype.

Haptoglobin serves to scavenge hemoglobin that escapes into the plasma and carries it to the liver parenchyma (11) and to macrophages (12). There is no a priori reason to believe that the haptoglobin pathway is an important limiting factor in iron homeostasis. One reason is that the vast majority of hemoglobin iron does not pass through this pathway; it has been estimated that the flow that can be attributed to free hemoglobin represents only 10% of the total hemoglobin normally catabolized (13), and this may well be an overestimate because it depends on measurement of plasma hemoglobin concentrations, which usually contain a substantial artifactual component. Another reason is that major disturbances of iron metabolism have not been reported in patients with anhaptoglobinemia attributable to a deletion of a portion of the haptoglobin cluster on chromosome 16q22 (14)(15). Moreover, the haptoglobin knockout mouse (16) has not been reported to have any abnormality of iron homeostasis, and healthy infants generally have no detectable haptoglobin (17). However, there is a recent body of evidence suggesting that there is a relationship between the haptoglobin type and serum ferritin concentrations (3)(4)(5).

It has been proposed that in patients homozygous for the C282Y mutation, transferrin saturation and ferritin concentrations are higher in those with the haptoglobin 2-2 type, although there seems to be no greater prevalence of liver fibrosis. In the present investigation we were unable to confirm these results in our population of patients. Indeed, the ferritin concentrations were actually lower, albeit not significantly so, in 2-2 homozygotes than in patients with other haptoglobin types. This was true even when the analysis was limited to the white patients in the sample (data not shown). The population of patients we studied was based on patients who had been diagnosed on the basis of their genotype, not because of biochemical changes or clinical stigmata of the disease. In contrast, the studies performed by others were based on patients who had been diagnosed as having hemochromatosis, presumably largely because of increased serum transferrin saturation and ferritin concentrations. Because our population was more diverse, it permitted a more incisive examination of the question of whether there is a true relationship between iron concentrations and the haptoglobin phenotype, the patients with low iron within the homozygous group serving as controls for those with high iron. However, we detected no difference.

There is no ready explanation for the discrepancy between our results and those reported by other authors, although it is possible that the putative effects of haptoglobin type are actually attributable to linkage dysequilibrium with other genes or to population stratification with respect to ethnic origin. It is of interest, in this regard, that no relationship between iron concentrations and haptoglobin phenotype could be found in an African population (18). In any case, the effect must be a minor one and cannot explain the large difference in the homozygous C282Y phenotype.


   Acknowledgments
 
This is manuscript number 15178-MEM. This work was supported by National Institutes of Health Grants DK53505 and RR00833 and the Stein Endowment Fund.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-337.[Abstract/Free Full Text]
  2. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of the 845G6A (C282Y) HFE hereditary haemochromatosis mutation in the U S A. Lancet 2002;359:211-218.[ISI][Medline] [Order article via Infotrieve]
  3. Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clin Chem Lab Med 2002;40:212-216.[ISI][Medline] [Order article via Infotrieve]
  4. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, De Buyzere ML, et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000;46:1619-1625.[Abstract/Free Full Text]
  5. Van Vlierberghe H, Langlois M, Delanghe J, Horsmans Y, Michielsen P, Henrion J, et al. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol 2001;35:707-711.[ISI][Medline] [Order article via Infotrieve]
  6. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms in homozygotes for the C282Y mutation of the HFE gene. Mayo Clin Proc 2002;77:522-530.[ISI][Medline] [Order article via Infotrieve]
  7. Craig WY, Forster NR, Ledue TB, Johnson AM, Neveux LM, Ritchie RF. An improved method for determining high molecular weights by protein immunoblotting: application to apolipoprotein(a) phenotyping. Appl Theor Electrophor 1991;2:135-140.[Medline] [Order article via Infotrieve]
  8. Beutler E. Discrepancies between genotype and phenotype in hematology: an important frontier. Blood 2001;98:2597-2602.[Abstract/Free Full Text]
  9. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802.[ISI][Medline] [Order article via Infotrieve]
  10. Lee PL, Halloran C, Trevino R, Felitti V, Beutler E. Human transferrin G277S mutation: a risk factor for iron deficiency anaemia. Br J Haematol 2001;115:329-333.[ISI][Medline] [Order article via Infotrieve]
  11. Okuda M, Tokunaga R, Taketani S. Expression of haptoglobin receptors in human hepatoma cells. Biochim Biophys Acta 1992;1136:143-149.[Medline] [Order article via Infotrieve]
  12. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SKA, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.[Medline] [Order article via Infotrieve]
  13. Garby L, Noyes WD. Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man. J Clin Invest 1959;38:1479.
  14. Koda Y, Soejima M, Yoshioka N, Kimura H. The haptoglobin-gene deletion responsible for anhaptoglobinemia. Am J Hum Genet 1998;62:245-252.[ISI][Medline] [Order article via Infotrieve]
  15. Nishiki S, Hino M, Kumura T, Hashimoto S, Ohta K, Yamane T, et al. Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody. Transfus Med 2002;12:71-73.[ISI][Medline] [Order article via Infotrieve]
  16. Lim SK, Kim HK, Bin A, Lim YK, Wang YP, Chong SM, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998;92:1870-1877.[Abstract/Free Full Text]
  17. Kanakoudi F, Drossou V, Tzimouli V, Diamanti E, Konstantinidis T, Germenis A, et al. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995;41:605-608.[Abstract/Free Full Text]
  18. Kasvosve I, Gordeuk VR, Delanghe JR, Gomo ZAR, Gangaidzo IT, Khumalo H, et al. Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med 2002;40:810-813.[ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Petrak, D. Myslivcova, P. Man, R. Cmejla, J. Cmejlova, D. Vyoral, M. Elleder, and C. D. Vulpe
Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1490 - G1498.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem., June 1, 2006; 52(6): 950 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
T R Zaccariotto, E T Rosim, D Melo, P M D Garcia, R R Munhoz, F H Aoki, and M de Fatima Sonati
Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population.
J. Clin. Pathol., May 1, 2006; 59(5): 550 - 553.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Tolosano, S. Fagoonee, C. Garuti, L. Valli, N. C. Andrews, F. Altruda, and A. Pietrangelo
Haptoglobin modifies the hemochromatosis phenotype in mice
Blood, April 15, 2005; 105(8): 3353 - 3355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Fagoonee, J. Gburek, E. Hirsch, S. Marro, S. K. Moestrup, J. M. Laurberg, E. I. Christensen, L. Silengo, F. Altruda, and E. Tolosano
Plasma Protein Haptoglobin Modulates Renal Iron Loading
Am. J. Pathol., April 1, 2005; 166(4): 973 - 983.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Van Vlierberghe and J. Delanghe
Haptoglobin Polymorphism and Iron Hemostasis
Clin. Chem., April 1, 2003; 49(4): 708 - 709.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beutler, E.
Right arrow Articles by Lee, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beutler, E.
Right arrow Articles by Lee, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Hematology
Right arrow Endocrinology and Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS